PharmaLectures.com

Courses › Regulatory affairs by region › United States: Who really buys generics in America, pricing, GPOs and the channel

United States: Who really buys generics in America, pricing, GPOs and the channel

Your sales team stops quoting discounts that quietly shift your Medicaid rebates.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

A salesperson agrees a deeper discount with a hospital buying group on a call. Weeks later, government pricing cannot show an auditor whether that discount was counted in or kept out of the Average Manufacturer Price. The wholesaler chargebacks that follow sit in dispute while payment waits.

What changes after this course

Your team checks each quote against Wholesale Acquisition Cost and Average Manufacturer Price rules, and spots Medicaid rebate effects before a Group Purchasing Organization deal is signed. You hold a certificate per learner and a per-person training record.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Before you answer a hospital that wants a deeper discount, you check whether it touches the Average Manufacturer Price, which drives the 340B Drug Pricing Program ceiling price and your Medicaid rebate. Business development drafts Group Purchasing Organization contracts with the administrative fee written to fit the Anti-Kickback Statute safe harbor, with sole-source clauses that protect your margin. Legal sees a clean draft the first time.

Regulatory affairs plans the Abbreviated New Drug Application around Paragraph IV certification and the 180-day period a first filer can earn. The filing date and the launch plan sit on one timeline, so approval day finds a price, a customer list and a wholesaler agreement ready. The launch price comes from the competitive bidding cycle, not from last year's assumptions.

A chargeback arrives and finance checks it in a set order: contract price, customer eligibility, then wholesaler sales and inventory data. Deductions with no matching contract line go back unpaid. Quality assurance and supply chain staff trace stock through the wholesaler channel, so a data mismatch is found at the claim, not argued over after the quarter closes.

Anyone who reports or sets a price can answer the auditor on the spot. The False Claims Act, the Anti-Kickback Statute and the Prescription Drug Marketing Act stop being three names on a legal memo and become checks built into the quote, the discount and the sample log. When a competitor is approved or a bill is proposed, the team already knows which contracts to reopen.

Who needs this training

  • Business Development Manager

    A hospital buying group asks for a deeper discount on Thursday. You check whether it reaches the Average Manufacturer Price, which sets the 340B ceiling price, and whether it fits the safe harbor before you reply, not after the contract is signed.

  • Regulatory Affairs Manager

    The Abbreviated New Drug Application is nearly ready and commercial asks for a launch date. You set the filing date, the Paragraph IV strategy and the 180-day period against a launch plan commercial can actually use.

  • Quality Assurance Manager

    A wholesaler disputes a chargeback because its inventory report and your shipment records disagree. You trace the batch through the channel and show where the numbers split, instead of waiting for finance to ask.

  • Government Pricing Manager

    An auditor asks how a new discount fed your Average Manufacturer Price and Unit Rebate Amount. You answer from the contract file and the calculation, with the False Claims Act in mind, on the same day.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: United States

Courses are in English. Other languages on request.

After this course your people can

  1. Calculate the Unit Rebate Amount for a new generic from its Average Manufacturer Price and show each input to an auditor.
  2. Draft the administrative fee clause of a Group Purchasing Organization contract so it fits the Anti-Kickback Statute safe harbor.
  3. Check a wholesaler chargeback against the contract price and the customer's eligibility before approving the deduction.
  4. Set the Abbreviated New Drug Application filing date against Paragraph IV certification and the 180-day first-filer period.
  5. Reprice a generic when a second or third competitor enters, and show how the change affects your Medicaid liability.
  6. Keep a drug sample record that meets the Prescription Drug Marketing Act.
  7. Explain how the 340B Drug Pricing Program ceiling price changes a hospital quote before you send it.

What the company gets

  • Chargeback deductions get paid only when they match a contract line, so revenue stops leaking to claims nobody checked.
  • Discount decisions reach government pricing before they reach the customer, so a Medicaid rebate surprise stops being the way you find out.
  • Regulatory filings and commercial readiness run on one timeline, so a generic is not approved into a market the team is not ready to sell in.
  • Auditor questions about discount structures and Anti-Kickback Statute compliance get answers from the contract file and the training record, not from memory.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min

Course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Trace who buys, who pays and who keeps the margin on your generic

    • Why a hospital system's contract decides your volume long before a pharmacist ever sees your label.
    • How to explain, in one slide, where the generic margin goes between manufacturer, wholesaler and payer.
    • The point where a pharmacy substitutes your generic for the brand, and who made that call.
  2. 2Apply Wholesale Acquisition Cost and Average Manufacturer Price to a quote

    • How Wholesale Acquisition Cost becomes the yardstick your customers hold your discount against.
    • The Average Sales Price formula that decides what Medicare Part B pays a provider for your product.
    • What moves your Average Manufacturer Price, so no concession changes a Medicaid rebate unnoticed.
  3. 3Calculate your Medicaid Drug Rebate Program liability before a price change

    • How to work out your Unit Rebate Amount and show the auditor each input behind it.
    • Why the 340B Drug Pricing Program ceiling price belongs in the quote, not in the dispute that follows.
    • What to do when a new price pushes your Medicaid liability up after the contract is already signed.
  4. 4Draft Group Purchasing Organization contracts that fit the safe harbor

    • Why Group Purchasing Organizations decide which generic a hospital buys, and how to get on the contract.
    • How to word the administrative fee clause so it fits the Anti-Kickback Statute safe harbor.
    • The clauses that protect your margin when you commit to be a sole-source supplier.
  5. 5Control which wholesalers carry your product and on what terms

    • When a wholesaler channel beats direct distribution for your product, and when it does not.
    • The checks your finance team runs before it pays any chargeback, in the order that catches errors first.
    • What to do when inventory data from the wholesaler does not match your sales records.
  6. 6Time the Abbreviated New Drug Application and launch around Paragraph IV

    • How a Paragraph IV certification puts a first filer in line for the 180-day period, and what can cost it.
    • The regulatory steps that stand between your filing and the first day you can ship.
    • When to file so the commercial team has a price and a customer list ready on approval day.
  7. 7Set a launch price that holds when a second and third generic arrive

    • How competitive bidding cycles set your opening price, and where to read them before you quote.
    • The role an authorized generic plays at launch, and what it does to the other generics on the market.
    • What to do when a third manufacturer enters a market you thought was settled.
  8. 8Process payer rebates and trace each chargeback to its contract

    • How to follow one chargeback from the pharmacy claim back to the contract line that justifies it.
    • The difference between a volume rebate and a prompt-pay discount, and where each lands in your books.
    • Why deductions paid without a match quietly cut your net price, and how to stop paying them.
  9. 9Test each discount against the False Claims Act and Anti-Kickback Statute

    • How the False Claims Act reaches the pricing data your team reports, and what keeps that data defensible.
    • The sample-tracking records the Prescription Drug Marketing Act requires, ready when someone asks for them.
    • What the Anti-Kickback Statute says about discounts offered to prescribers, and where the line sits.
  10. 10Adjust your pricing model ahead of competitor approvals and policy change

    • How each new competitor approval lowers the price floor, and when to move before your customers ask.
    • Why Pharmacy Benefit Managers change formulary preferences over time, and how to spot the shift early.
    • What recent legislative proposals mean for your long-term reimbursement, in terms your planners can use.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team